Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Kimball International Inc is a furnishings, fixtures & appliances business based in the US. Kimball International shares (KBAL) are listed on the NASDAQ and all prices are listed in US Dollars. Kimball International employs 2,196 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$11.04|
|52-week range||$9.81 - $14.64|
|50-day moving average||$11.63|
|200-day moving average||$12.83|
|Wall St. target price||$17.50|
|Dividend yield||$0.36 (3.24%)|
|Earnings per share (TTM)||$0.20|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-2.30%|
|1 month (2021-09-17)||-4.08%|
|3 months (2021-07-16)||-11.61%|
|6 months (2021-04-16)||-21.14%|
|1 year (2020-10-16)||-1.60%|
|2 years (2019-10-17)||-44.33%|
|3 years (2018-10-17)||16.21|
|5 years (2016-10-17)||12.8|
Valuing Kimball International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Kimball International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Kimball International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 55x. In other words, Kimball International shares trade at around 55x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Kimball International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $26.4 million.
The EBITDA is a measure of a Kimball International's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$569 million|
|Operating margin TTM||0.92%|
|Gross profit TTM||$182.4 million|
|Return on assets TTM||0.79%|
|Return on equity TTM||3.06%|
|Market capitalisation||$404.7 million|
TTM: trailing 12 months
There are currently 369,014 Kimball International shares held short by investors – that's known as Kimball International's "short interest". This figure is 1% up from 365,425 last month.
There are a few different ways that this level of interest in shorting Kimball International shares can be evaluated.
Kimball International's "short interest ratio" (SIR) is the quantity of Kimball International shares currently shorted divided by the average quantity of Kimball International shares traded daily (recently around 172436.44859813). Kimball International's SIR currently stands at 2.14. In other words for every 100,000 Kimball International shares traded daily on the market, roughly 2140 shares are currently held short.
However Kimball International's short interest can also be evaluated against the total number of Kimball International shares, or, against the total number of tradable Kimball International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kimball International's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Kimball International shares in existence, roughly 10 shares are currently held short) or 0.0103% of the tradable shares (for every 100,000 tradable Kimball International shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Kimball International.
Find out more about how you can short Kimball International stock.
Dividend payout ratio: 1.03% of net profits
Recently Kimball International has paid out, on average, around 1.03% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Kimball International shareholders could enjoy a 3.26% return on their shares, in the form of dividend payments. In Kimball International's case, that would currently equate to about $0.36 per share.
While Kimball International's payout ratio might seem low, this can signify that Kimball International is investing more in its future growth.
Kimball International's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 September 2021 (the "ex-dividend date").
Kimball International's shares were split on a 1281:1000 basis on 2 November 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1281 shares. This wouldn't directly have changed the overall worth of your Kimball International shares – just the quantity. However, indirectly, the new 21.9% lower share price could have impacted the market appetite for Kimball International shares which in turn could have impacted Kimball International's share price.
Over the last 12 months, Kimball International's shares have ranged in value from as little as $9.8113 up to $14.6413. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kimball International's is 0.9476. This would suggest that Kimball International's shares are less volatile than average (for this exchange).
Kimball International, Inc. engages in the manufacture and sale of furniture products under the Kimball, National, Etc. , Interwoven, Kimball Hospitality, D'style, and Poppin brands in the United States and internationally. The company offers desks/workstations, benching, seating, lounge, storage, tables, and casegoods for collaborative and open workspaces, conference and meeting/huddle rooms, training rooms, private offices, learning areas, classrooms, lobby/reception areas, and dining/café areas; and headboards, tables, seating, vanities, casegoods, lighting, and other products for hotel properties, and commercial and residential mixed use developments. It also provides desks and benching, adjustable height desks, office chairs and stools, file cabinets, tables, lounge seating, PoppinSpaces, and PoppinPods for workspace, as well as furniture solutions for healthcare markets. Kimball International, Inc. markets and sells its products through sales representatives, office furniture dealers, wholesalers, brokers, designers, purchasing companies, and catalog houses, as well as online to end users.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.